TY  - GEN
AU  - Powles,Thomas
AU  - Blank,Christian
AU  - Chowdhury,Simon
AU  - Horenblas,Simon
AU  - Peters,John
AU  - Shamash,Jonathan
AU  - Sarwar,Naveed
AU  - Boleti,Ekaterini
AU  - Sahdev,Anju
AU  - O'Brien,Tim
AU  - Berney,Dan
AU  - Beltran,Luis
AU  - Nathan,Paul
AU  - Haanen,John
AU  - Bex,Axel
TI  - The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
SN  - 1873-7560
PY  - 2011///1207
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Clinical Trials, Phase II as Topic
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Nephrectomy
KW  - adverse effects
KW  - Patient Selection
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - Pyrroles
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sunitinib
KW  - Survival Rate
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.eururo.2011.05.028
ER  -